ARTICLE | Company News
Apitope, Merck KGaA deal
January 19, 2009 8:00 AM UTC
Merck KGaA's Merck Serono S.A. subsidiary received exclusive, worldwide rights to develop and commercialize Apitope's ATX-MS-1467. The vaccine containing four peptides derived from human myelin basi...